Advertisement

Topics

Companies Related to "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" [Most Relevant Company Matches] - Page: 2 RSS

22:02 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" found in our extensive corporate database of over 50,000 company records.

Showing "Trial Maraviroc Combination With Optimized Background Therapy Versus" Companies 26–50 of 2,200+

Relevant

Viralytics Limited

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia. Oncolytic virotherapy makes use of the cancer destroyi...


Orphan Technologies

Orphan Technologies is dedicated to developing novel therapies to dramatically improve the lives of patients suffering from the rare disorder, homocystinuria and related diseases. OT-58, our lead drug development candidate, has been optimized as an enzyme replacement therapy for classical homocystinuria, a genetic disease characterized by debilitating card...

Cisive

Cisive is a global provider of compliance-driven human capital management and risk management solutions. The company’s core onboarding and pre-employment background screening offering provides clients with a streamlined, high quality, and regulatory compliant solution. Comprehensive services include background screening, vendor/contractor screening, e...


Iinvivodata

invivodata is the worldwide leader in capturing clinical trial data of the highest integrity directly from patients. With a unique combination of scientific, technological, and regulatory expertise, invivodata has pioneered the evolution of the electronic Patient Reported Outcomes (ePRO) industry and continues to provide innovative methods that make it easy for clinical trial sponsors to attain th...

9zest

9zest’s mission is to enhance quality of life by leveraging neuroplasticity principles through physical therapy, occupational therapy, yoga, speech therapy and meditation for debilitating conditions such as Parkinson’s, Stroke, and Chronic Pain.

Probably Relevant

Advantage Physical Therapy Associates, LLC

Founded in 2005, Advantage Physical Therapy Associates is an independent physical therapy practice with Pennsylvania-based offices in Columbia, Dover, East York, Emigsville, Lancaster, New Oxford, and Red Lion. For more information about Advantage Physical Therapy Associates and its services, go to www.gettheadvantage.org.

Physical Therapy Pal

Physical Therapy Pal (PT PAL) is the first clinical HIPAA-compliant mobile application used between physical therapists and patients. PT PAL helps improve outcomes by engaging patients in their therapy. PT PAL gives visibility into patient regimen adherence and the ability to monitor and modify therapy prescriptions remotely. PT PAL is an aid ...

Sirbal Ltd.

Sirbal Ltd. was founded by Mr. Nadav Shraibom, a Chinese Herbal Medicine Clinician, with Messrs. Tal Dilian and Eran Steinberg as co-founders. Its mission is to provide safe and efficient treatments for inflammatory diseases. Its first products based on a multi-herbal botanical extract, SIRB-001, clinically establishes clear efficacy and safety in topical ...

Vaxon Biotech.

Vaxon Biotech, founded in early 2004 and based in Evry Genopole - France, is a product-driven biopharmaceutical company focusing on the discovery and development of innovative vaccines for the treatment of malignancies, including prostate, lung, breast and colon cancer. The company is based on an original discovery made by Dr. Kostas Kosmatopoulos and his team: optimized cryptic peptides. Vaxon Bi...

Quantum Clinical Research

Global Clinical Trial/Project Management Therapeutic Specialization Phase I Clinical Trial Mgmt Capabilities Phase II-III Capabilities Phase IIIb –IV Capabilities Post marketing Surveillance Treatment IND & Compassionate Use Regulatory Operations & QA Capabilities Worldwide Drug Safety Clinical Trial Monitoring CRA/Monitor Training Select Biometrics Capabilities

CRDE Sp. j.

CRDE was founded in 2002 as niche CRO focused on managing clinical trials phase I-IV in oncology, metabolic disorders, cardiovascular disorders and pediatrics. Such therapeutic areas are very demanding and require specialized knowledge to understand study design and procedures, endpoints, safety issues and patient populationsOur Medical and Clinical Operations staff have proven experience and appl...

Athletico Physical Therapy

Athletico Physical Therapy provides the highest quality orthopedic rehabilitation services to communities and organizations, with 88 locations throughout Illinois, Wisconsin and Indiana. To demonstrate our commitment to both our patients and referring physicians, we measure functional patient outcomes and patient satisfaction with national data comparis...

Nextrials, Inc

Nextrials is an innovative, award-winning, ileader in web-based software solutions for the clinical research industry. Prism®, the Company’s clinical trial management software, brings together sophisticated trial management and electronic data capture (“EDC”) in a single package enabling clinical researchers to derive more value from trial data, accelerate time to market and substantially l...

Clinical Research Associate

Clinical Research Associate, also known as a Monitor, is an individual that oversees the progress and conduct of a clinical trial. A clinical trial is usually implemented by physicians at a hospital, clinic, or physician's office. The CRA is required to oversee the initiation, progress, and conduct of the clinical trial to ensure the scientific integrity of the data collected, and the protection o...

RealTimePrimers

RealTimePrimers.com is dedicated to providing low cost, optimized primer sets for researchers utilizing quantitative real time PCR. When used with high quality template and other reagents, our products have been designed and optimized to produce clean PCR products. As SYBR green-based real time PCR assays continue to be reliable and the most cost-effective approach to measuring gene expression, ...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Excel PharmaStudies Inc.

Top leading contract research organization (CRO) in China. We could provide a full range of services including: product registration, conducting clinical trial and global trial, as well as statistic analysis and data management.

Slope.io

Slope.io is a clinical trial supply chain logistics company. The company uses a modern, data-driven technology platform with predictive analytics to enable patient-centered, automated and end-to-end integrated services for clinical trial supplies. Trial data powers automated, just-in-time delivery of clinical supplies to study sites. For more information, ...

TransPerfect Trial Interactive

TransPerfect Life Science Solutions provides leading web-based platforms, including eTMFs, that enable sponsors, CROs, IRBs, central laboratories and other vendors to maintain and update clinical trial documentation in a secure online collaborative environment. The Trial Interactive platform enables fully searchable solutions including eTMFs and investigat...

Akron Biotechnology, LLC

As a global supplier, Akron Biotech (www.akronbiotech.com) manufactures and distributes components and raw materials for cell therapy discovery, development and commercialization, meeting the industry’s needs worldwide. The Company’s unique business model emphasizes flexibility, quality and unparalleled service from research and development throu...

Cyberonics Sorin

Cyberonics, Inc. is a medical device company with core expertise in neuromodulation. The company developed and markets the VNS Therapy® System, which is FDA-approved for the treatment of medically refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the...

Clinical Research Advantage, Inc.

Tempe, Ariz.-based Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations (CROs). As a leading trial management organization (TMO), CRA operates from 29 sites across 12 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and e...

Wilhelmsen Consulting

Wilhelmsen Consulting and its network of associates provide chemical, environmental and food related technical expertise to a broad range of clients. Dr. Eric Wilhelmsen, the founder and principle consultant, has a multidisciplinary background in Analytical Chemistry, Biotechnology, Environmental Science, Food Science and Technology, and Nutrition. This background and a diverse network of associ...

Genetix Pharmaceuticals, Inc.

Genetix Pharmaceuticals, Inc. is an emerging leader in treatments for severe genetic disorders based on a breakthrough gene therapy platform that uses a patient’s own genes to treat his/her disorder. Taking stem cells from a patient’s own bone marrow, Genetix uses a proprietary lentiviral technology to modify the genes and deliver corrective stem ...

DHP pharma

DHP specialises in the preparation, packaging and distribution of Investigational Medicinal Products and Clinical Trial Supplies for study phases 1 through 4 and subsequent compassionate use.All work is carried out in accordance with the EU Clinical Trial Directive 2001/20 and Good Manufacturing Practice as set out by the MHRA. DHP offers a meticulous and comprehensive service from design through ...


More From BioPortfolio on "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks